Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677012 · ClinicalTrials.gov registry record
Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT02677012: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02677012 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02677012 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This randomized clinical trial studies and compares 3 techniques in performing autologous fat grafting (AFG) in patients undergoing surgery to reshape or rebuild (reconstruct) a part of the body changed by previous surgery and inserted into another part of the body. AFG, also called fat injections or fat transplant, is a procedure in which an individual's own body fat (usually from abdomen or legs) is used during reconstructive surgery. Doctors want to compare 3 techniques for processing the fat tissue collected during surgery and the length of time needed to complete each AFG technique and surgery. Comparing 3 AFG techniques and the time to complete them during surgery may help doctors determine the best technique to perform fat grafting in the future.
Interventions
- PROCEDURE Autologous Fat Graft
- PROCEDURE Reconstructive Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-02-04 |
| Est. Completion | 2020-07-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02677012
The ClinicalTrials.gov registry entry for NCT02677012 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autologous Fat Graft is the first listed.
NCT02677012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02677012 about?
NCT02677012 is a clinical study titled "Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery". This randomized clinical trial studies and compares 3 techniques in performing autologous fat grafting (AFG) in patients undergoing surgery to reshape or rebuild (reconstruct) a part of the body changed by previous surgery and inserted into another part of the body. AFG, also called fat injections o...
What is the current status of trial NCT02677012?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-02-04. Estimated completion is 2020-07-03.
What interventions are being tested in trial NCT02677012?
The interventions under investigation include: Autologous Fat Graft (PROCEDURE), Reconstructive Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02677012?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.